Helping Oncology Patients Through Holistic Wellness

Video

Holistic wellness and helping patients manage the toxins in their outside life are just a few of the focuses at Wobbly Arrow Wellness.

Pharmacy Times spoke with holistic oncology pharmacist Jenna Carmichael from Wobbly Arrow Wellness about how she started in this specific industry and how she helps her patients navigate the ups and downs of cancer treatments.

Recent Videos
Oncology, MARIPOSA Trial, Lung Cancer | Image Credit: Konstantin Yuganov - stock.adobe.com
Image Credit: © Sophie - stock.adobe.com
Image Credit: © Beaunitta Van Wyk/peopleimages.com - stock.adobe.com
Affordable Oncology Care | Image Credit: Pixel-Shot - stock.adobe.com
Image Credit: © Lucija - stock.adobe.com.
patient, chemotherapy, steroids, car, side effects, drugs, treatment plan, dose, immunosuppression, pharmacist, build, transplant, oncology, infection, risk, pharmacy, prolongs, seizure medications, happened, medications
Image Credit: © Pixel-Shot - stock.adobe.com.
Non Small Cell Lung Cancer (NSCLC) in the lung tissue – closeup view 3d illustration
patients, btk, therapy, important, inhibitor, agents, mutation, bcl, targeted therapy, factor, toxicity, cll, influence, treatment, response, mutational, gave, chronic lymphocytic leukemia, targeted, ngs
lymphoma, mrd, assays, trials, tests, tumor, subtypes, guide, tracking, treatment, therapy, reporters, identify, circulating, sequencing, patients, results, mantle cell lymphoma, tumor dna, seq
Related Content
Image of solid tumors -- Image credit: JAEMIN | stock.adobe.com

Inavolisib Shows Promising Disease Control Rates, Safety in Patients With PIK3CA-Mutated Solid Tumors

Gillian McGovern, Assistant Editor
September 20th 2024
Article
Pharmacy Focus- Oncology Edition: Delayed Breast Cancer Screenings

Pharmacy Focus- Oncology Edition: Delayed Breast Cancer Screenings

August 29th 2024
Podcast
FDA Approves Amivantamab-vmjw for NSCLC With EGFR Exon 19 Deletions or L858R Mutations

FDA Approves Amivantamab-vmjw for NSCLC With EGFR Exon 19 Deletions or L858R Mutations

Aislinn Antrim, Assistant Managing Editor
September 20th 2024
Article
Pharmacy Focus - Oncology Edition: The Link Between Gut Health and Colon Cancer, Exploring the Wellness Innovation Network

Pharmacy Focus - Oncology Edition: The Link Between Gut Health and Colon Cancer, Exploring the Wellness Innovation Network

July 30th 2024
Podcast
Image Credit: © tongpatong - stock.adobe.com

Fam-Trastuzumab Deruxtecan Shows Positive Results for HER2-Positive Breast Cancer with Brain Metastases

Alexandra Gerlach, Associate Editor
September 19th 2024
Article
New Pembrolizumab Data Presented at ESMO Show Promise in a Variety of Cancers

New Pembrolizumab Data Presented at ESMO Show Promise in a Variety of Cancers

Aislinn Antrim, Assistant Managing Editor
September 19th 2024
Article